Investigation of E–H mode transition in magnetic-pole-enhanced inductively coupled neon–argon mixture plasma

In this paper, E–H mode transition in magnetic-pole-enhanced inductively coupled neon–argon mixture plasma is investigated in terms of fundamental plasma parameters as a function of argon fraction(0%–100%), operating pressure(1 Pa, 5 Pa, 10 Pa and 50 Pa), and radio frequency(RF) power(5–100 W). An RF compensated Langmuir probe and optical emission spectroscopy are used for the diagnostics of the plasma under study. Owing to the lower ionization potential and higher collision cross-section of argon, when its fraction in the discharge is increased, the mode transition occurs at lower RF power; i.e. for 0% argon and1 Pa pressure, the threshold power of the E–H mode transition is 65 W, which reduces to 20 W when the argon fraction is increased. The electron density increases with the argon fraction at afixed pressure, whereas the temperature decreases with the argon fraction. The relaxation length of the low-energy electrons increases, and decreases for high-energy electrons with argon fraction, due to the Ramseur effect. However, the relaxation length of both groups of electrons decreases with pressure due to reduction in the mean free path. The electron energy probability function(EEPF) profiles are non-Maxwellian in E-mode, attributable to the nonlocal electron kinetics in this mode; however, they evolve to Maxwellian distribution when the discharge transforms to H-mode due to lower electron temperature and higher electron density in H-mode. The tail of the measured EEPFs is found to deplete in both E-and H-modes when the argon fraction in the discharge is increased, because argon has a much lower excitation potential(11.5 eV) than neon(16.6 eV).     

Antioxidant Protective Effect of Glibenclamide and Metformin in Combination with Honey in Pancreas of Streptozotocin-Induced Diabetic Rats

Hyperglycemia exerts toxic effects on the pancreatic β-cells. This study investigated the hypothesis that the common antidiabetic drugs glibenclamide and metformin, in combination with tualang honey, offer additional protection for the pancreas of streptozotocin (STZ)-induced diabetic rats against oxidative stress and damage. Diabetes was induced in male Sprague Dawley rats by a single dose of STZ (60 mg/kg; ip). Diabetic rats had significantly elevated levels of lipid peroxidation (TBARS), up-regulated activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx) while catalase (CAT) activity was significantly reduced. Glibenclamide and metformin produced no significant effects on TBARS and antioxidant enzymes except GPx in diabetic rats. In contrast, the combination of glibenclamide, metformin and honey significantly up-regulated CAT activity and down-regulated GPx activity while TBARS levels were significantly reduced. These findings suggest that tualang honey potentiates the effect of glibenclamide and metformin to protect diabetic rat pancreas against oxidative stress and damage.     

Controlled release of Montelukast Sodium from pH-sensitive injectable hydrogels

pH sensitive hydrogels showed excellent drug release properties, with promise for other biomedical applications. Also, the impact of molecular weight (MW) and degree of deacetylation (DDA) of chitosan on the fabricated chitosan/poly (vinyl alcohol) (3:1 mol ratio) hydrogel with selective silane crosslinker amount was evaluated for controlled drug delivery. The FTIR spectroscopy confirmed the incorporated components and the developed interactions among the polymer chains. The hydrogel characteristics were expressed by their responsive behaviour in different environments (water, ionic media and pH). The hydrogel sample (CH1000) having chitosan with higher MW and DDA exhibited more thermal stability and bacterial growth inhibition against E.coli. All hydrogels exhibited maximum swelling at basic and neutral pH and less swelling was observed in acidic media. For drug release analysis performed in simulated gastric fluid, hydrogel showed controlled drug release in 2 h but it was more than 10%, consequently cannot be used for oral purpose. In simulated intestinal fluid, hydrogels exhibited more than 80% release within 90 min. This characteristic phenomenon at neutral pH empowered hydrogel appropriate towards injectable and targeted controlled release of applicable drug. It was concluded that the prepared hydrogel can be administered directly into the venous circulation through syringe and can be used with better results for biomedical applications.